CCC Intelligent Solutions to go private in $6.1B deal
Get Alerts CCC Hot Sheet
Join SI Premium – FREE
CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC) has agreed to be acquired by a consortium led by GTCR and Elliott Investment Management L.P. in an all-cash transaction valued at approximately $6.1 billion, according to a press release from the Chicago-based company.
Under the terms of the agreement, CCC stockholders will receive $7.75 per share in cash. That price represents a premium of approximately 44% to CCC's closing stock price on July 9, 2026, the last trading day before media reports surfaced regarding a potential sale, and a premium of approximately 59% to the 30-day average price as of that date.
The transaction was approved by CCC's Board of Directors and is expected to close in the first quarter of 2027, subject to regulatory approvals and CCC stockholder approval. The deal is not subject to a financing condition. Upon closing, CCC will become a privately held company and its shares will be delisted from the Nasdaq.
CCC Chairman and CEO Githesh Ramamurthy said the announcement follows a review of strategic options conducted with the assistance of financial and legal advisors.
Morgan Stanley is serving as financial advisor to CCC, with Kirkland & Ellis LLP acting as legal counsel. J.P. Morgan is acting as lead financial advisor to GTCR and lead arranger of committed financing, with Citi also serving as financial advisor. Simpson Thacher & Bartlett LLP is legal counsel to GTCR, while Gibson, Dunn & Crutcher LLP and Debevoise & Plimpton LLP are advising Elliott.
CCC connects more than 35,000 businesses across the insurance and automotive repair sector. The company is scheduled to release its third-quarter 2026 financial results on October 29, 2026, though it will not host a conference call given the pending transaction.
You May Also Be Interested In
- Bolt Biotherapeutics acquires Prana Therapies, raises $120M
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
- Vertex's povetacicept hits key endpoints in Phase 3 kidney disease trial
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
JPMorgan, Citi, Morgan Stanley, Elliott Associates, GTCR, Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share